Vertex Pharmaceuticals Incorporated
CRYSTALLINE FORMS OF MODULATORS OF CFTR

Last updated:

Abstract:

Crystalline Forms of Compound (I); crystalline Forms of Compound (II) and crystalline forms of pharmaceutically acceptable salts of any of the foregoing are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed. ##STR00001##

Status:
Application
Type:

Utility

Filling date:

29 Mar 2019

Issue date:

14 Jan 2021